新生儿急性呼吸窘迫综合征的治疗进展

Advances in the treatment of neonatal acute respiratory distress syndrome

多种原因引起的急性呼吸窘迫综合征（ARDS）是新生儿临床常见的危重症。随着新生儿重症监护及诊疗技术的不断发展与进步，新生儿ARDS的治愈率有所提高，但病死率仍然在30%～40%。新生儿ARDS目前尚无特效的治疗措施，主要根据其病理生理改变和临床表现采取综合性治疗。现将新生儿ARDS的治疗进展作一综述。

Acute respiratory distress syndrome （ARDS） caused by various reasons is a common severe neo- natal clinical disease. The cure rate of the ARDS in newborns increases with the constantly progress of the neonatal intensive care and diagnosis medical technology. However, the morality of ARDS in newborn infants is still very high, about 30% - 40%. There is no special therapy with neonatal ARDS and comprehensive treatment is adopted mainly according to its pathophysiologic change and clinical manifestation. The review will summarize the advances in the treatment of neonatal ARDS.